CDP 571: Completed Phase IIa trial

Celltech Group plc, Slough, U.K. Product: CDP 571 human anti- tumor necrosis factor alpha antibody Indication: Rheumatoid arthritis Status: Completed Phase IIa trial in 36 patients, with results to be...